T46.4X2
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by angiotensin-converting enzyme (ACE) inhibitors due to intentional self-harm refers to cases where an individual deliberately ingests or exposes themselves to these medications with the intention of causing harm. ACE inhibitors are commonly prescribed for high blood pressure and heart failure, but abuse or overdose can lead to serious health complications. Recognizing the causes, symptoms, and treatment options is essential for healthcare providers and caregivers.
Causes & Symptoms
Clinical Causes: Intentional overdose in an attempt to harm oneself Suicidal ideation or behavior related to mental health disorders Misuse of medication due to misunderstanding of dosage instructions Revenge or manipulation involving medication ingestion
Key Symptoms: Low blood pressure (hypotension) Dizziness or lightheadedness Weakness or fatigue Nausea and vomiting Blurred vision Kidney dysfunction or failure Electrolyte imbalances, such as high potassium levels
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on a combination of patient history, physical examination, and laboratory tests. Healthcare providers will evaluate recent medication intake, signs of low blood pressure, kidney function, and electrolyte levels. Blood tests including serum potassium, renal function tests, and toxicology screens may be employed to confirm poisoning and assess severity.
Treatment Protocols: Management focuses on stabilizing the patient and reversing the effects of the overdose. Initial steps often include:
Clinical Advice & FAQs
Billing Guidance
Is T46.4X2 a billable ICD-10 code?
Yes, T46.4X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.4X2?
Clinical documentation must specify the nature of Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference